NCKAP1 and cholangiocarcinoma: We demonstrated elevated expression levels of NCKAP1 in multiple cancer types, including cholangiocarcinoma (CHOL), head and neck squamous cell carcinoma (HNSC), liver hepatocellular carcinoma (LIHC), and stomach adenocarcinoma (STAD).